Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19
Status:
Not yet recruiting
Trial end date:
2021-08-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the clinical efficacy of Isoquercetin in
preventing disease progression and symptoms improvement in mild-to-moderate hospitalised
COVID-19 patients.